These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

57 related items for PubMed ID: 16707252

  • 1. Multidrug resistance to antimicrobials as a predominant factor influencing patient survival.
    Giamarellos-Bourboulis EJ, Papadimitriou E, Galanakis N, Antonopoulou A, Tsaganos T, Kanellakopoulou K, Giamarellou H.
    Int J Antimicrob Agents; 2006 Jun; 27(6):476-81. PubMed ID: 16707252
    [Abstract] [Full Text] [Related]

  • 2. Experimental sepsis using Pseudomonas aeruginosa: the significance of multi-drug resistance.
    Giamarellos-Bourboulis EJ, Koussoulas V, Panagou C, Adamis T, Baziaka F, Skiadas I, Perrea D, Dionyssiou-Asteriou A, Giamarellou H.
    Int J Antimicrob Agents; 2004 Oct; 24(4):357-61. PubMed ID: 15380261
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Outcome of infections caused by multiple drug-resistant bacteria in liver transplant recipients.
    Gouvêa EF, Branco RC, Monteiro RC, Halpern M, Ribeiro-Filho J, Silveira VG, Tavares GC, Rodrigues MS, Coelho HS, Basto ST, Santoro-Lopes G.
    Transplant Proc; 2004 May; 36(4):958-60. PubMed ID: 15194333
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand.
    Koomanachai P, Tiengrim S, Kiratisin P, Thamlikitkul V.
    Int J Infect Dis; 2007 Sep; 11(5):402-6. PubMed ID: 17291803
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pseudomonas aeruginosa bacteremia over a 10-year period: multidrug resistance and outcomes in transplant recipients.
    Johnson LE, D'Agata EM, Paterson DL, Clarke L, Qureshi ZA, Potoski BA, Peleg AY.
    Transpl Infect Dis; 2009 Jun; 11(3):227-34. PubMed ID: 19302282
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prediction models to identify hospitalized patients at risk of being colonized or infected with multidrug-resistant Acinetobacter baumannii calcoaceticus complex.
    Tacconelli E, Cataldo MA, De Pascale G, Manno D, Spanu T, Cambieri A, Antonelli M, Sanguinetti M, Fadda G, Cauda R.
    J Antimicrob Chemother; 2008 Nov; 62(5):1130-7. PubMed ID: 18635519
    [Abstract] [Full Text] [Related]

  • 13. Antimicrobial susceptibility of Pseudomonas aeruginosa isolates obtained from patients in Canadian intensive care units as part of the Canadian National Intensive Care Unit study.
    Walkty A, Decorby M, Nichol K, Mulvey MR, Hoban D, Zhanel G, Canadian Antimicrobial Resistance Alliance.
    Diagn Microbiol Infect Dis; 2008 Jun; 61(2):217-21. PubMed ID: 18304774
    [Abstract] [Full Text] [Related]

  • 14. Characterization of multidrug-resistant Salmonella enterica serovar Heidelberg isolated from humans and animals.
    Patchanee P, Zewde BM, Tadesse DA, Hoet A, Gebreyes WA.
    Foodborne Pathog Dis; 2008 Dec; 5(6):839-51. PubMed ID: 18991546
    [Abstract] [Full Text] [Related]

  • 15. Antimicrobial therapy and control of multidrug-resistant Pseudomonas aeruginosa bacteremia in a teaching hospital in Taiwan.
    Leung CH, Wang NY, Liu CP, Weng LC, Hsieh FC, Lee CM.
    J Microbiol Immunol Infect; 2008 Dec; 41(6):491-8. PubMed ID: 19255693
    [Abstract] [Full Text] [Related]

  • 16. [Multidrug resistant clones of Pseudomonas aeruginosa in the Czech Republic].
    Nemec A, Maixnerová M, Musílek M.
    Klin Mikrobiol Infekc Lek; 2008 Oct; 14(5):168-72. PubMed ID: 19051164
    [Abstract] [Full Text] [Related]

  • 17. Impact of multidrug resistance on experimental empyema by Pseudomonas aeruginosa.
    Giamarellos-Bourboulis EJ, Tzepi I, Tsovolou I, Spyridaki A, Tsaganos T, Vaki I, Kotsaki A, Polychronopoulos V.
    Respiration; 2011 Oct; 82(1):46-53. PubMed ID: 21525725
    [Abstract] [Full Text] [Related]

  • 18. Molecular characterisation of Canadian paediatric multidrug-resistant Streptococcus pneumoniae from 1998-2004.
    Zhanel GG, Wang X, Nichol K, Nikulin A, Wierzbowski AK, Mulvey M, Hoban DJ.
    Int J Antimicrob Agents; 2006 Nov; 28(5):465-71. PubMed ID: 17049211
    [Abstract] [Full Text] [Related]

  • 19. Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia.
    Peralta G, Sánchez MB, Garrido JC, De Benito I, Cano ME, Martínez-Martínez L, Roiz MP.
    J Antimicrob Chemother; 2007 Oct; 60(4):855-63. PubMed ID: 17644532
    [Abstract] [Full Text] [Related]

  • 20. Streptococcus pneumoniae: does antimicrobial resistance matter?
    Lynch JP, Zhanel GG.
    Semin Respir Crit Care Med; 2009 Apr; 30(2):210-38. PubMed ID: 19296420
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.